|

Brentuximab Vedotin 50 MG [Adcetris] Clinical Trials

1 actively recruiting trial

Also known as: Nivolumab, Pembrolizumab

Pipeline

Phase 2/3: 1

Top Sponsors

  • Hospital Regional de Alta Especialidad del Bajio1

Indications

  • Relapsed Hodgkin's Disease, Adult1
  • Refractory Hodgkin Lymphoma1
  • Hodgkin Lymphoma1
  • Cancer1

Other1 trial

Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma
Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.